Reference:
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, David S, Thokala P, Wailoo A, Jefferys M, Hyde C. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimers disease (review of Technology Appraisal No.111): a systematic review and economic model. Health Technology Assessment 2012;16(21): 1-470.